HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer

BACKGROUND: HAGE protein is a known immunogenic cancer-specific antigen. METHODS: The biological, prognostic and predictive values of HAGE expression was studied using immunohistochemistry in three cohorts of patients with BC (n=2147): early primary (EP-BC; n=1676); primary oestrogen receptor-negati...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdel-Fatah, T M A, McArdle, S E B, Johnson, C, Moseley, P M, Ball, G R, Pockley, A G, Ellis, I O, Rees, R C, Chan, S Y T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021517/
https://www.ncbi.nlm.nih.gov/pubmed/24755885
http://dx.doi.org/10.1038/bjc.2014.168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021517/
https://www.ncbi.nlm.nih.gov/pubmed/24755885
http://dx.doi.org/10.1038/bjc.2014.168

Ejemplares similares